September 19, 2017

U.S. FDA Grants Fast Track Designation for Amicus Therapeutics' Migalastat for Treatment of Fabry Disease

September 14, 2017

Amicus Therapeutics Announces Approval for Galafold™ (Migalastat) for Treatment of Fabry Disease in Canada

September 13, 2017

Amicus Therapeutics Announces Top-Line Phase 3 Results for SD-101 in Epidermolysis Bullosa